JAZZ: Jazz Pharmaceuticals plc Stock

by  •  • Comments Off on JAZZ: Jazz Pharmaceuticals plc Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 7,445.59
Enterprise Value ($M) 11,339.25
Book Value ($M) 4,171.07
Book Value / Share 69.00
Price / Book 1.79
NCAV ($M) -3,694.23
NCAV / Share -61.11
Price / NCAV -2.02

Profitability (mra)
Return on Invested Capital (ROIC) 0.04
Return on Assets (ROA) 0.04
Return on Equity (ROE) 0.12

Liquidity (mrq)
Quick Ratio 3.74
Current Ratio 4.26

Balance Sheet (mrq) ($M)
Current Assets 4,390.42
Assets 12,255.72
Liabilities 8,084.65
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Vanguard Group Inc 10.11 -1.79
01-24 13G/A BlackRock, Inc. 11.20 6.06

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-14 72,464 393,952 18.39
2025-01-13 87,011 451,782 19.26
2025-01-10 91,715 369,343 24.83

(click for more detail)

Similar Companies
IPSC – Century Therapeutics, Inc. IRWD – Ironwood Pharmaceuticals, Inc.
ITCI – Intra-Cellular Therapies, Inc. KMDA – Kamada Ltd.
KNSA – Kiniksa Pharmaceuticals, Ltd.


Financial data and stock pages provided by
Fintel.io